Crabb, Simon J.
Birtle, Alison J.
Martin, Karen
Downs, Nichola
Ratcliffe, Ian
Maishman, Tom
Ellis, Mary
Griffiths, Gareth
Thompson, Stuart
Ksiazek, Lidia
Khoo, Vincent
Jones, Robert J.
Funding for this research was provided by:
Cancer Research UK (C9317/A16029, CRUK/12/042)
Article History
Received: 14 November 2016
Accepted: 16 January 2017
First Online: 1 February 2017
Compliance with ethical standards
:
: SJC has undertaken consulting or advisory roles for Bayer, Sanofi, Astellas, Janssen, Pfizer and Roche and has received research funding from AstraZeneca, Astex Pharmaceuticals and Plexxikon. GG has undertaken consulting or advisory roles for Sirtex, GlaxoSmithKline and Pfizer. All other authors declare that they have no conflicts of interest.
: This work was supported by Cancer Research UK [C9317/A16029, CRUK/12/042], Cancer Research UK core funding to the Southampton Clinical Trials Unit and AstraZeneca.
: All procedures performed in this clinical trial were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.